Kurs
+0,34%
Likviditet
0,02 MNOK
Kalender
| Tid* | ||
| 2025-08-29 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-22 | N/A | Årsstämma |
| 2025-02-27 | N/A | Bokslutskommuniké 2024 |
| 2024-08-28 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-27 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2024-05-24 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-22 | - | 15-10 2023-Q3 |
| 2023-08-31 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-26 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2023-05-25 | - | Årsstämma |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-23 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-31 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-27 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2022-05-25 | - | Årsstämma |
| 2022-05-11 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-18 | - | Bokslutskommuniké 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-31 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-31 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2021-05-28 | - | Årsstämma |
| 2021-05-07 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-24 | - | Bokslutskommuniké 2020 |
| 2020-11-11 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-26 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-28 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2020-05-27 | - | Årsstämma |
| 2020-05-06 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-26 | - | Bokslutskommuniké 2019 |
| 2019-11-27 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-31 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2019-05-29 | - | Årsstämma |
| 2019-05-08 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-13 | - | Bokslutskommuniké 2018 |
| 2018-11-13 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-30 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-30 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2018-05-29 | - | Årsstämma |
| 2018-05-08 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-19 | - | Bokslutskommuniké 2017 |
| 2017-11-28 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-29 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-30 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2017-05-29 | - | Årsstämma |
| 2017-05-16 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-28 | - | Bokslutskommuniké 2016 |
| 2016-12-08 | - | Extra Bolagsstämma 2016 |
| 2016-11-22 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-30 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-20 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2016-05-19 | - | Årsstämma |
| 2016-05-03 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-09 | - | Bokslutskommuniké 2015 |
| 2015-11-17 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-18 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-13 | - | X-dag ordinarie utdelning PCIB 0.00 NOK |
| 2015-05-12 | - | Årsstämma |
| 2015-05-12 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-24 | - | Bokslutskommuniké 2014 |
| 2014-11-18 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-19 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-14 | - | X-dag ordinarie utdelning |
| 2014-05-13 | - | Årsstämma |
| 2014-05-13 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-25 | - | Bokslutskommuniké 2013 |
| 2013-10-29 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-20 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-07 | - | X-dag ordinarie utdelning |
| 2013-05-06 | - | Årsstämma |
| 2013-04-30 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-21 | - | Bokslutskommuniké 2012 |
| 2012-10-30 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-21 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-08 | - | Kvartalsrapport 2012-Q1 |
| 2012-04-26 | - | X-dag ordinarie utdelning |
| 2012-04-25 | - | Årsstämma |
| 2012-02-07 | - | Bokslutskommuniké 2011 |
| 2011-11-01 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-23 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-10 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | X-dag ordinarie utdelning |
| 2010-10-25 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-23 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-19 | - | X-dag ordinarie utdelning |
| 2010-05-18 | - | Årsstämma |
| 2010-04-26 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-18 | - | Bokslutskommuniké 2009 |
| 2009-10-26 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-20 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-29 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Oslo, Norway, 23 August 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2024 interim report on Wednesday 28 August 2024, 08:30am – 09:00am CEST (local time).
The presentation will be held as a live webcast available through www.pcibiotech.com. The presentation will be held in Norwegian. There will be a Q&A session at the end of the presentation and it will be possible to post written questions through the webcast console. The interim report and presentation will be made available on www.newsweb.no and on the company's webpage, www.pcibiotech.com, from 07.00am CEST the same day.
For further information, please contact:
Ronny Skuggedal, CEO / CFO
Email: rs@pcibiotech.no
Mobile: +47 9400 5757
About PCI Biotech
PCI Biotech is a biopharmaceutical company focusing on developing and commercialising new technologies and novel therapies through its photochemical technology platform originating from world-leading research at the Oslo University Hospital. The technology platform is under development in two different areas. (1) Photochemical lysis (PCL), inducing selective light-triggered cell lysis, which may enhance yield and purity in viral vector manufacturing. (2) Photochemical internalisation (PCI), inducing light-triggered endosomal release, which may unlock the potential of a wide array of modalities.
For further information, please visit: www.pcibiotech.com
Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo
Forward-looking statements
This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements. PCI Biotech disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.